{"product_id":"bodypharm-tirzepatide-pen-60mg-1","title":"BodyPharm Tirzepatide PEN 60mg","description":"\u003cp data-start=\"440\" data-end=\"620\"\u003eTirzepatide is a peptide studied extensively for its activity across key metabolic and incretin pathways. It functions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"583\" data-end=\"608\"\u003edual receptor agonist\u003c\/strong\u003e, acting on:\u003c\/p\u003e\n\u003cul data-start=\"622\" data-end=\"736\"\u003e\n\u003cli data-start=\"622\" data-end=\"669\"\u003e\n\u003cp data-start=\"624\" data-end=\"669\"\u003e\u003cstrong data-start=\"624\" data-end=\"669\"\u003eGLP-1 (glucagon-like peptide-1) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"670\" data-end=\"736\"\u003e\n\u003cp data-start=\"672\" data-end=\"736\"\u003e\u003cstrong data-start=\"672\" data-end=\"736\"\u003eGIP (glucose-dependent insulinotropic polypeptide) receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"738\" data-end=\"939\"\u003eThrough this dual mechanism, tirzepatide has been investigated for its effects on insulin secretion, regulation of hepatic glucose production, delayed gastric emptying, and appetite-related signalling.\u003c\/p\u003e\n\u003cp data-start=\"941\" data-end=\"1136\"\u003eThis product is supplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"298\" data-start=\"269\"\u003epre-filled injectable pen\u003c\/strong\u003e intended for purchasers who have independently researched the compound and are operating under appropriate professional guidance.\u003c\/p\u003e\n\u003chr data-start=\"1138\" data-end=\"1141\"\u003e\n\u003ch3 data-start=\"1143\" data-end=\"1182\"\u003eClinical Trial Evidence (Phase 3)\u003c\/h3\u003e\n\u003cp data-start=\"1183\" data-end=\"1279\"\u003eTirzepatide has undergone extensive\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1219\" data-end=\"1250\"\u003ePhase 3 clinical evaluation\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003ein large, controlled trials.\u003c\/p\u003e\n\u003cul data-start=\"1281\" data-end=\"1735\"\u003e\n\u003cli data-start=\"1281\" data-end=\"1563\"\u003e\n\u003cp data-start=\"1283\" data-end=\"1563\"\u003eIn Phase 3 studies conducted under controlled conditions, tirzepatide demonstrated\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1366\" data-end=\"1421\"\u003esubstantial and sustained reductions in body weight\u003c\/strong\u003e, with participants achieving\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1451\" data-end=\"1524\"\u003eaverage weight reductions of up to approximately 22–23% over 72 weeks\u003c\/strong\u003e, depending on dose and study protocol.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"1564\" data-end=\"1735\"\u003e\n\u003cp data-start=\"1566\" data-end=\"1735\"\u003ePhase 3 programmes also evaluated long-term safety, tolerability, and metabolic outcomes, forming the basis for subsequent regulatory approvals in certain jurisdictions.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp data-start=\"1737\" data-end=\"1882\"\u003eOutcomes observed in clinical trials are dependent on controlled protocols and\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"1816\" data-end=\"1881\"\u003edo not guarantee similar results outside of clinical settings\u003c\/strong\u003e.\u003c\/p\u003e\n\u003chr data-start=\"1884\" data-end=\"1887\"\u003e\n\u003ch3 data-start=\"1889\" data-end=\"1919\"\u003eHow Tirzepatide Compares\u003c\/h3\u003e\n\u003cp data-start=\"1920\" data-end=\"1991\"\u003eTirzepatide is often discussed alongside other incretin-based peptides:\u003c\/p\u003e\n\u003cul data-start=\"1993\" data-end=\"2233\"\u003e\n\u003cli data-start=\"1993\" data-end=\"2057\"\u003e\n\u003cp data-start=\"1995\" data-end=\"2057\"\u003e\u003cstrong data-start=\"1995\" data-end=\"2010\"\u003eSemaglutide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003efunctions as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2026\" data-end=\"2057\"\u003eGLP-1 receptor agonist only\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2058\" data-end=\"2141\"\u003e\n\u003cp data-start=\"2060\" data-end=\"2141\"\u003e\u003cstrong data-start=\"2060\" data-end=\"2075\"\u003eTirzepatide\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2081\" data-end=\"2097\"\u003edual agonist\u003c\/strong\u003e, targeting both\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-start=\"2114\" data-end=\"2141\"\u003eGLP-1 and GIP receptors\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"2142\" data-end=\"2233\"\u003e\n\u003cp data-start=\"2144\" data-end=\"2233\"\u003eThis dual activity differentiates tirzepatide from earlier single-pathway GLP-1 compounds\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2055\" data-start=\"2052\"\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003ch3 data-end=\"2082\" data-start=\"2057\"\u003eImportant Information\u003c\/h3\u003e\n\u003cul data-end=\"2441\" data-start=\"2083\"\u003e\n\u003cli data-end=\"2145\" data-start=\"2083\"\u003e\n\u003cp data-end=\"2145\" data-start=\"2085\"\u003eSupplied as a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"298\" data-start=\"269\"\u003epre-filled injectable pen\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2211\" data-start=\"2146\"\u003e\n\u003cp data-end=\"2211\" data-start=\"2148\"\u003eNo dosing, administration, or medical instructions are provided\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2367\" data-start=\"2266\"\u003e\n\u003cp data-end=\"2367\" data-start=\"2268\"\u003eConsultation with a\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2320\" data-start=\"2288\"\u003elicensed healthcare provider\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eis essential prior to any consideration of use\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2441\" data-start=\"2368\"\u003e\n\u003cp data-end=\"2441\" data-start=\"2370\"\u003eResults observed in clinical trials may not reflect real-world outcomes\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-end=\"2446\" data-start=\"2443\"\u003e\n\u003ch3 data-end=\"2481\" data-start=\"2448\"\u003e\u003cbr\u003e\u003c\/h3\u003e\n\u003cp data-end=\"2588\" data-start=\"2482\"\u003eThis product is supplied strictly on an\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2550\" data-start=\"2522\"\u003einformed purchaser basis\u003c\/strong\u003e. By purchasing, you acknowledge that:\u003c\/p\u003e\n\u003cul data-end=\"3029\" data-start=\"2590\"\u003e\n\u003cli data-end=\"2671\" data-start=\"2590\"\u003e\n\u003cp data-end=\"2671\" data-start=\"2592\"\u003eYou have independently researched this product and its investigational status\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2748\" data-start=\"2672\"\u003e\n\u003cp data-end=\"2748\" data-start=\"2674\"\u003eYou have consulted, or will consult, a qualified healthcare professional\u003cbr\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"2943\" data-start=\"2860\"\u003e\n\u003cp data-end=\"2943\" data-start=\"2862\"\u003eThe seller provides\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"2941\" data-start=\"2882\"\u003eno medical advice, treatment claims, or dosing guidance\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-end=\"3029\" data-start=\"2944\"\u003e\n\u003cp data-end=\"3029\" data-start=\"2946\"\u003eThe\u003cspan\u003e \u003c\/span\u003e\u003cstrong data-end=\"3029\" data-start=\"2950\"\u003eonus of lawful, safe, and appropriate use rests entirely with the purchaser\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"Vitality Lab","offers":[{"title":"Default Title","offer_id":43251183485041,"sku":null,"price":3100.0,"currency_code":"ZAR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0681\/2457\/3809\/files\/Screenshot2026-05-18124650.png?v=1779101125","url":"https:\/\/vitalitylab.co.za\/products\/bodypharm-tirzepatide-pen-60mg-1","provider":"Vitality Lab","version":"1.0","type":"link"}